A Chitosan-PLGA based catechin hydrate nanoparticles used in targeting of lungs and cancer treatment

Autor: Hassan Mohammed Ali Almatar, Aftab Alam, Ridha Abdullah Alrasheed, Rizwan Ahmad, Niyaz Ahmad, Taysser Mohammed Buheazah, Hassan Ali Al-Nasif, Hussain Salman AlHomoud, Abdullah Sami Al-Ramadan
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0106 biological sciences
0301 basic medicine
Apoptosis
CS
chitosan

Pharmacology
01 natural sciences
PVA
polyvinyl alcohol

Chitosan
chemistry.chemical_compound
DSC
differential scanning calorimetry

CC
calibration curve

IS
internal standard

lcsh:QH301-705.5
EE
entrapment efficiency

ANOVA
analysis of variance

Tmax
time to Cmax

Chemistry
LLOQQC
lower limit of quantification for quality control

TEM
transmission electron microscope

CTH
Catechin hydrate

respiratory system
CS-CTH-PLGA-NPs
LOD
lower limit of detection

DCM
dichloromethane

LC
loading capacity

PLGA
Kel
elimination rate constant

Toxicity
LLOQ
liquid–liquid extraction: LLE: lower limit of quantification

CH-S
catechin-hydrate-suspension

Lung cancer
General Agricultural and Biological Sciences
Quercetin
SEM
scanning electron microscope

Cmax
PBS
phosphate buffered solution

macromolecular substances
AUC
area under curve

CS-CTH-PLGA-NPs
chitosan-coated catechin hydrate-loaded-PLGA-nanoparticles

UHPLC-MS/MS
ultra high performance liquid chromatography mass spectroscopy and mass spectroscopy

Article
Cmax
maximum plasma concentration

MQC
low quality control: LQC: middle quality control

03 medical and health sciences
medicine
NPs
nanoparticles

Lungs comparative pulmokinetics
LOQ
lower limit of quantitation

technology
industry
and agriculture

Cancer
PDI
polydispersity index


half-life

medicine.disease
Catechin hydrate
Bioavailability
030104 developmental biology
lcsh:Biology (General)
UHPLC-MS/MS
ESI
Electrospray ionization

HQC
high quality control

Cancer cell
010606 plant biology & botany
Zdroj: Saudi Journal of Biological Sciences, Vol 27, Iss 9, Pp 2344-2357 (2020)
Saudi Journal of Biological Sciences
Popis: Objective: To prepare a novel Chitosan (CS)-coated-PLGA-NPs of catechin hydrate (CTH) and to improve lungs bioavailability via direct nose to lungs-delivery for the comparative assessment of a pulmokinetics study by the first-time UHPLC-MS/MS developed method in the treatment of lungs cancer via anticancer activities on H1299 lung cancer cells. Material and methods: PLGA-NPs was prepared by solvent evaporation (double emulsion) method followed by coated with chitosan (CS) and evaluated based on release and permeation of drug, a comparative pulmokinetics study with their anticancer activities on H1299 lung cancer cells. Results: The particle size, PDI and ZP of the optimized CAT-PLGA-NPs and CS-CAT-PLGA-NPs were determined 124.64 ± 12.09 nm and 150.81 ± 15.91 nm, 0.163 ± 0.03 and 0.306 ± 0.03, –3.94 ± 0.19 mV and 26.01 ± 1.19 mV respectively. Furthermore, higher entrapment efficiency was observed for CS-CAT PLGA NPs. The release pattern of the CS-CAT-PLGA NPs was found to favor the release of entrapped CAT within the cancer microenvironment. CS-CAT-PLGA-NPs exposed on H1299 cancer cells upto 24.0 h was found to be higher cytotoxic as compared to CAT-solution (CAT-S). CS-CAT-PLGA-NPs showed higher apoptosis of cancer cells after their exposure as compared to CAT-S. CS-CTH-PLGA-NPs showed tremendous mucoadhesive-nature as compared to CTH-S and CS-CTH-PLGA NPs by retention time (RT) of 0.589 min, and m/z of 289.21/109.21 for CTH alongwith RT of 0.613 min and m/z of 301.21/151.21 was found out for IS (internal standard), i.e. Quercetin). Likewise, for 1–1000 ng mL−1 (linear range) of % accuracy (92.01–99.31%) and %CV (inter & intra-day, i.e. 2.14–3.33%) was determined. The improved Cmax with AUC0–24 was observed extremely significant (p
Databáze: OpenAIRE